-
Residents recount guilt, chaos in hearing on deadly Hong Kong fire
-
Oil prices jump, stocks slip as Trump's Iran claims raise doubts
-
World Snooker Championship to stay at Crucible
-
Mercedes new electric VLE: Price and performance?
-
Outlook worsens for whale stranded on German coast
-
Xiaomi quarterly profit slumps despite annual EV gains
-
Iran, Israel trade strikes despite Trump talk of negotiations
-
IPL's Bengaluru to keep 11 seats empty in honour of stampede dead
-
Oil prices jump, stocks waver after Trump's Iran claim
-
'A top person': Who is the US dealing with in Iran?
-
In Lebanon's Tyre, ancient site threatened by Israeli bombs
-
US-Israeli war on Iran is 'breach of international law': German president
-
Iran strikes Israel, denies Trump talks
-
Mbappe says injury is behind him, all systems go for World Cup
-
Supporters' group file lawsuit against 'excessive' World Cup ticket prices
-
Gas shortages push India's poor back to wood and coal
-
'Plundered': Senegal fishers feel sting of illegal, industrial vessels
-
Iran hits Israel with missiles after denying Trump talks
-
Stocks rise on Trump U-turn but unease sees oil bounce
-
Trans community alarmed as India moves to curb LGBTQ rights
-
Families' nightmare fight for justice in Austria child sex cases
-
Tiger Woods to return to action in TGL with Masters looming
-
Australia, EU agree sweeping new trade pact eight years in the works
-
Back to black: facing energy shock, Asia turns to coal
-
Iran fires new wave of missiles at Israel after denying Trump talks
-
Manila's jeepney drivers struggle as Mideast war sends diesel cost soaring
-
The contenders vying to be next Danish leader
-
India's historic haveli homes caught between revival and ruin
-
Denmark votes in close election, outgoing PM tipped to win
-
N. Korea's Kim vows 'irreversible' nuclear status, warns Seoul of 'merciless' response
-
Pressure on Italy as play-off hopefuls eye 2026 World Cup
-
Malinin and Sakamoto seek solace at figure skating worlds as Olympic champions absent
-
'Perfect Japan' posts spark Gen Z social media backlash
-
Asian stocks rise on Trump U-turn but unease sees oil bounce
-
Pistons halt Lakers streak while Spurs, Thunder win
-
Silence not an option, says Canadian Sikh activist after fresh threats
-
Rennie shakes up All Blacks backroom team as 2027 World Cup looms
-
Australia, EU agree to sweeping new trade pact after eight years
-
Too old? The 92-year-old US judge handling Maduro case
-
Australia, EU agree sweeping new trade pact
-
Sinner, Sabalenka march on in Miami as more seeds crash out
-
US social media addiction trial jury struggles for consensus
-
EU 'concerned' by reports Hungary leaked information to Russia
-
USPA Global and ESPN Expand Relationship with Chris Fowler for 2026 High-Goal Polo Championships
-
EU chief meets Australian PM as trade talks enter 'last mile'
-
Israel pounds south Beirut, says captured Hezbollah members
-
EU chief to meet Australian PM as trade talks enter 'last mile'
-
Champion Mensik, Medvedev dumped out of Miami Open
-
Jury at US social media addiction trial reports 'difficulty' in finding consensus
-
Stokes eager to lead England recovery after 'hardest period of captaincy'
Court to hear lawsuit seeking to ban abortion pill in US
A Texas judge favored by anti-abortion activists will hear arguments Wednesday in an unprecedented challenge to the legality of a widely-used abortion pill.
US District Court Judge Matthew Kacsmaryk announced Monday the hearing on a lawsuit alleging the US Food and Drug Administration (FDA) should never have approved the "dangerous" prescription drug Mifepristone in 2000.
Mifepristone, one component of a two-drug regimen used for medication abortion, has been used by an estimated 5.6 million women to terminate pregnancies since its approval, according to the FDA.
It is can be used in the United States up to 10 weeks of pregnancy.
The pro-abortion rights Guttmacher Institute estimates that more than half of all abortions involve the use of mifepristone.
But the Alliance Defending Freedom, a Christian advocacy group, sued the FDA saying its approval "disavow(ed)" science, "ignored" potential health impacts and "disregarded" the complications that can arise with using mifepristone.
"The FDA failed America's women and girls when it chose politics over science and approved chemical abortion drugs for use in the United States," they said.
Galvanized by the Supreme Court's ruling in June that overturned the constitutional right to an abortion, abortion opponents have now set their sights on obtaining prohibitions on mifepristone.
Already the treatment has been halted in some 15 states which have banned all abortion since the 2022 Supreme Court decision.
The Texas suit seeks to block it nationally by overturning the FDA's approval of the drug.
The FDA has urged the judge to reject the request.
"The public interest would be dramatically harmed by effectively withdrawing from the marketplace a safe and effective drug that has lawfully been on the market for 22 years," it said.
Kacsmaryk was targeted by the plaintiffs to hear the case due to his deep conservative Christian beliefs and previous anti-abortion stance.
He had been expected since February 24 to issue a ruling in the case, which asks him to suspend the FDA's approval of the drug while the lawsuit proceeds.
Apparently fearing protestors descending on the courthouse in Amarillo, Texas, Kacsmaryk originally sought to keep the hearing secret until the last minute, but it leaked to media.
If he does order the suspension, it could leave pregnant women with the alternative of using only misoprostol, the second pill in the medication abortion treatment.
But using misoprostol alone is more physically traumatic than the two-pill procedure, and some fear doctors might be unwilling to prescribe it alone.
If mifepristone is banned, "access to medication abortion would end across the country -- even in those states where abortion rights are protected," the Center for Reproductive Rights said.
Z.AlNajjar--SF-PST